Torrent Pharma reinforces its leadership in domestic formulations while focusing on operational efficiency and profitable growth across global markets, despite external challenges. Torrent Pharmaceuticals (TRP) continues to strengthen its market position, achieving consistent growth in Q3 FY25, led by its robust domestic formulations (DF) business. The company navigated currency-related headwinds in Brazil and subdued activity … Continue reading Torrent Pharma’s Strategic Focus Powers Domestic Growth in Q3 FY25